Document is current
Any future updates will be listed below
-
Authors
Bruins, M. E.
Prins, L. I.
Pels, A.
Groen, H.
Løkkegaard, E. C.L.
Jacquemyn, Y.
Scholz, A.
Onland, W.
Leemhuis, A. G.
Papageorghiou, A. T.
Figueras, F.
Gordijn, S. J.
Ganzevoort, W.
-
Funding
Funding for this research was provided by:
HORIZON EUROPE European Research Council (ERC, FGR PODS, 101086156)
HORIZON EUROPE European Research Council (ERC, FGR PODS, 101086156)
HORIZON EUROPE European Research Council (ERC, FGR PODS, 101086156)
HORIZON EUROPE European Research Council (ERC, FGR PODS, 101086156)
HORIZON EUROPE European Research Council (ERC, FGR PODS, 101086156)
HORIZON EUROPE European Research Council (ERC, FGR PODS, 101086156)
HORIZON EUROPE European Research Council (ERC, FGR PODS, 101086156)
HORIZON EUROPE European Research Council (ERC, FGR PODS, 101086156)
HORIZON EUROPE European Research Council (ERC, FGR PODS, 101086156)
HORIZON EUROPE European Research Council (ERC, FGR PODS, 101086156)
HORIZON EUROPE European Research Council (ERC, FGR PODS, 101086156)
HORIZON EUROPE European Research Council (ERC, FGR PODS, 101086156)
HORIZON EUROPE European Research Council (ERC, FGR PODS, 101086156)
Nemo Healthcare
ICT HCTS
Universitair Medisch Centrum Groningen
- License Information
-
More Information
Article History
Received: 7 July 2025
Accepted: 21 January 2026
First Online: 21 February 2026
Declarations
:
: Ethical board approval for the execution of this trial was obtained from the Central Committee on Research Involving Human Subjects on 14th October 2024 (protocol version 3.0 dated 19th July 2024, NL84591.000.24). Written, informed consent to participate will be obtained from all participants. Ethical approval for the follow-up study was obtained from the MREC Amsterdam UMC on 5th December 2025 (protocol version 2.0 dated 7th October 2025, 2025.0840).
: Not applicable - no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results.
: The sponsor has the final role in the study design; collection, management, analysis,interpretation of the data; writing of the report; and the decision to submit the report forpublication. The sponsor will have ultimate authority over any of these activities. Thefunding agency has provided funds to perform the study according to the predefined plan.It has no role or authority in any of these activities.
: The authors declare no competing interests.
